Clinical Trial Update: Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia [Phase 2]

View source ↗

Summary

A Phase 2 trial of miltefosine to treat cutaneous leishmaniasis in Bolivia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: AB Foundation | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: COMPLETED